{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"osteoporosis-oculocutaneous-hypopigmentation","columns":[{"gene":"","key":"population-c709935848bb3afd5746","label":"Osteoporosis-oculocutaneous hypopigmentation syndrome","mondoId":"MONDO:0011020","onsetQualifier":null,"originColumnKey":"MONDO:0011020/ORPHA:2786","originalViews":[{"key":"MONDO:0011020/ORPHA:2786","label":"Osteoporosis-oculocutaneous hypopigmentation syndrome","scopeLabel":"ORPHA:2786","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0a6f3b71b52196b6ce701ea5192356cc53b8635b865e71dbaa48f9d8db880cd0","1c08b59431275d61a9b02c895c1e0930cab6d8fcea6638b769ae8964faf5c762","3dd80dd0dfec48f3d299e7861349b33dca4403f71b349bb5985ea1e07b1e5ff4","41325bfe26593ae0cb8e6070ca088f1a60675485ed8b708e49c4bd97abaaafe7","a39cf47207ead830da260299fffbc06bfcd3fdafec370500945adac76d863bcd","a9a60067ea3146a858a22d3362d125821eae3db868a6eb5c25affa29f0d43eea","bd74807a54871ccecf81ef4edb45e68e858a18ea5f3de2f6970da6fe4c40f1f5","ca784d865631569c70659dca1f965b53d0c895699f8759de4ed073256c1d1885","d083fd329ec3bb5b5f68a3063a72bd1a07b8b34a9fba56b3aa1c9b68b6768432","e169fa17651bcfc67a238e4a4d6c75015215d1ff109d9d0f4d47e38eb83a5531","e2236a87ba37b869ff35f1bc19d5adcb301b6f976c7ce493d812666e37337f06","f42c60addff6644f87f180baa2e75a250c7ca0a0286076ba20e06afd2a287f3d"],"recordQualifiers":{},"scopeLabel":"ORPHA:2786","sourceIds":["ORPHA:2786"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-c709935848bb3afd5746"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000479","HP:0001022","HP:0005599","HP:0001010","HP:0002808","HP:0000545","HP:0000639"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":12,"sourceGroups":{"orphanet":12}},"features":[{"hpoId":"HP:0000479","label":"Abnormal retinal morphology","primary":true},{"hpoId":"HP:0001022","label":"Albinism","primary":true},{"hpoId":"HP:0005599","label":"Hypopigmentation of hair","primary":true},{"hpoId":"HP:0001010","label":"Hypopigmentation of the skin","primary":true},{"hpoId":"HP:0002808","label":"Kyphosis","primary":true},{"hpoId":"HP:0000545","label":"Myopia","primary":true},{"hpoId":"HP:0000639","label":"Nystagmus","primary":true},{"hpoId":"HP:0000939","label":"Osteoporosis","primary":false},{"hpoId":"HP:0000980","label":"Pallor","primary":false},{"hpoId":"HP:0000926","label":"Platyspondyly","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false}],"ledeHtml":"A rare genetic disease characterized by congenital oculocutaneous hypopigmentation, visual impairment, generalized osteoporosis with skeletal anomalies such as short stature, short neck and trunk, kyphosis, scoliosis, and platyspondyly, and dysmorphic facial features (including long philtrum, small mouth, micrognathia, and prominent ears). Moderate joint hyperelasticity and muscular hypotrophy have also been reported.","mondoId":"MONDO:0011020","node":{"canonicalSlug":"osteoporosis-oculocutaneous-hypopigmentation","comparisons":[{"documentSha256":"8b139d1bf134321a52c0d7eca29e60b00129f243afcfd76dfbde5373c3488b51","key":"legacy-osteoporosis-oculocutaneous-hypopigmentation","kind":"legacy","label":"osteoporosis-oculocutaneous hypopigmentation syndrome","memberIds":["MONDO:0011020"],"mondoId":"MONDO:0011020","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/osteoporosis-oculocutaneous-hypopigmentation.8b139d1bf134321a52c0d7eca29e60b00129f243afcfd76dfbde5373c3488b51.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","originalSourceId":"ORPHA:2786","paragraphs":["A rare genetic disease characterized by congenital oculocutaneous hypopigmentation, visual impairment, generalized osteoporosis with skeletal anomalies such as short stature, short neck and trunk, kyphosis, scoliosis, and platyspondyly, and dysmorphic facial features (including long philtrum, small mouth, micrognathia, and prominent ears). Moderate joint hyperelasticity and muscular hypotrophy have also been reported."],"rawAttribution":"MONDO:0011020","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:47Z","upstream":"MONDO:0011020","url":"https://rarediseases.info.nih.gov/diseases/404"},"ownColumnKeys":["population-c709935848bb3afd5746"],"publication":"published","relationships":[{"kind":"parent","label":"musculoskeletal system disorder","mondoId":"MONDO:0002081","slug":null},{"kind":"parent","label":"hereditary disease","mondoId":"MONDO:0003847","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0a6f3b71b52196b6ce701ea5192356cc53b8635b865e71dbaa48f9d8db880cd0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000926","is_excluded":false,"label":"Platyspondyly","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1c08b59431275d61a9b02c895c1e0930cab6d8fcea6638b769ae8964faf5c762","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000479","is_excluded":false,"label":"Abnormal retinal morphology","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3dd80dd0dfec48f3d299e7861349b33dca4403f71b349bb5985ea1e07b1e5ff4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000939","is_excluded":false,"label":"Osteoporosis","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"41325bfe26593ae0cb8e6070ca088f1a60675485ed8b708e49c4bd97abaaafe7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002808","is_excluded":false,"label":"Kyphosis","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a39cf47207ead830da260299fffbc06bfcd3fdafec370500945adac76d863bcd","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005599","is_excluded":false,"label":"Hypopigmentation of hair","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a9a60067ea3146a858a22d3362d125821eae3db868a6eb5c25affa29f0d43eea","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000980","is_excluded":false,"label":"Pallor","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bd74807a54871ccecf81ef4edb45e68e858a18ea5f3de2f6970da6fe4c40f1f5","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001010","is_excluded":false,"label":"Hypopigmentation of the skin","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ca784d865631569c70659dca1f965b53d0c895699f8759de4ed073256c1d1885","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001022","is_excluded":false,"label":"Albinism","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"d083fd329ec3bb5b5f68a3063a72bd1a07b8b34a9fba56b3aa1c9b68b6768432","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e169fa17651bcfc67a238e4a4d6c75015215d1ff109d9d0f4d47e38eb83a5531","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e2236a87ba37b869ff35f1bc19d5adcb301b6f976c7ce493d812666e37337f06","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f42c60addff6644f87f180baa2e75a250c7ca0a0286076ba20e06afd2a287f3d","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:2786","disease_name":"Osteoporosis-oculocutaneous hypopigmentation syndrome","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000545","is_excluded":false,"label":"Myopia","onset_id":null,"reference":"ORPHA:2786","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/404\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0011020\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0011020</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare genetic disease characterized by congenital oculocutaneous hypopigmentation, visual impairment, generalized osteoporosis with skeletal anomalies such as short stature, short neck and trunk, kyphosis, scoliosis, and platyspondyly, and dysmorphic facial features (including long philtrum, small mouth, micrognathia, and prominent ears). Moderate joint hyperelasticity and muscular hypotrophy have also been reported.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/404\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"osteoporosis-oculocutaneous-hypopigmentation","sourceDocuments":[{"name":"GARD: Osteoporosis-oculocutaneous hypopigmentation syndrome","reviewed":null,"source_release":"2026-10-21T17:04:47Z","url":"https://rarediseases.info.nih.gov/diseases/404"},{"name":"MONDO: osteoporosis-oculocutaneous hypopigmentation syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0011020"}],"sourceNote":"","synonyms":["Hernández-Fragoso syndrome","OOCH","OOCH syndrome","OOCHS","osteoporosis and oculocutaneous hypopigmentation syndrome","osteoporosis oculocutaneous hypopigmentation syndrome"],"takeawayHtml":"","title":"osteoporosis-oculocutaneous hypopigmentation syndrome"},"schemaVersion":1}
